A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity

Clinical trial NCT07728383 · RECRUITING

Trial details

NCT number: NCT07728383
Sponsor: Gila Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Obesity & Overweight

Start date: 2026-06-17
Primary completion: 2027-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.